Tylenol maker Kenvue to cut 4% jobs, ... Kenvue's stock is down 11% so far this year, and 13% from its IPO price since listing in May last year. Shares were up 2.3% in premarket trading on Tuesday.
Just after beating profit estimates for the first quarter of 2024, Kenvue (NYSE:KVUE) has announced plans to reduce its global workforce by 4%. Formerly a division of Johnson & Johnson (NYSE:JNJ ...
(Reuters) – Kenvue beat Wall Street estimates for first-quarter profit on Tuesday, and said it would cut 4% of its global workforce amid the Tylenol and Band-Aid maker’s efforts to expand its ...
Kenvue Inc.'s stock jumped 2% early Tuesday, after the consumer health business that was spun out of Johnson & Johnson last year posted better-than-expected first-quarter earnings and announced ...
, opens new tab announced on Tuesday that it plans to cut hundreds of jobs at its corporate headquarters and relocate a majority of its U.S. and Canada-based remote workforce to three offices, a ...
, opens new tab on-going $2 billion cost savings plan, a source familiar with the matter said on Tuesday. Nike had laid out a costs saving plan in December that would stretch over the next three ...
Kenvue, the consumer arm spun off from healthcare group Johnson & Johnson, has added Interpublic Group’s FCB and Omnicom’s BBDO to its global agency roster. The two agencies had both previously worked ...
(RTTNews) - Telstra Corp. Ltd. (TLSYY.PK, TLS.AX, TLS) announced plans to streamline its operations and cut costs, aiming to reduce its direct workforce by up to 2,800 jobs by the end of this year.
Jobs website Indeed is to cut 1,000 jobs globally, around 8% of its workforce. It is not yet known how many jobs will go at the company's Irish operation which employs more than 1,200 people.
SKILLMAN, N.J. - Kenvue Inc . (NYSE: NYSE:KVUE), a leading consumer health company, announced the initiation of a secondary underwritten public offering of 182,329,550 shares of its common stock today ...
Tylenol maker Kenvue has said that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.